ISMRM & ISMRT Annual Meeting & Exhibition • 03-08 June 2023 • Toronto, ON, Canada

ISMRM & ISMRT Annual Meeting & Exhibition

Weekday Course

Female Pelvis: Quantitative Imaging for Clinical Decisions

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

Female Pelvis: Quantitative Imaging for Clinical Decisions
Weekday Course
ORGANIZERS: Nandita deSouza
Tuesday, 06 June 2023
718A
13:30 -  15:30
Moderators: Mark Sugi
Session Number: Tu-04
CME Credit
Session Number: Tu-04

Overview
This course will address advances in quantitative imaging of common female malignancies and put them in the context of clinical decision-making in an era where tumor genotyping is increasingly used. The second part of this course will address new horizons of fetal and placental imaging and address the use of quantitative metrics for better diagnostics.


Target Audience
Intermediate to advanced participants with either a MR physics or radiology background with an interest in female pelvic imaging.


Educational Objectives
As a result of attending this course, participants should be able to:
- Explain the derivation and applications of quantitative MRI in gynecological malignancy; - Explain the derivation and applications of quantitative MRI metrics in fetal and placental imaging; and - Recognize clinical decision pathways where quantitative MRI can be employed in female pelvic imaging.

 
13:30   Ovarian Cancer: Is Quantitative MRI Needed? Laure Fournier

Keywords: Body: Pelvis

For ovarian cancer diagnosis, the O-RADS MRI score allows characterising the lesion as benign, borderline or malignant with very high predictive values. Though O-RADS itself does not integrate quantitation, quantitative imaging played a major role in establishing evidence, and more specifically developing the visual enhancement curves. At the (mostly peritoneal) metastatic stage, diffusion-weighted sequences have been used for detection and quantification of the Peritoneal Cancer Index, a predictor of resectability and survival. Finally, conventional imaging does not currently predict or monitor treatment response or recurrence, and more advanced quantitative techniques such as radiomics may supply some of the answers.
14:00   Endometrial Cancer: Can MRI Offer More Than a Staging Tool? Caroline Reinhold

Keywords: Body: Urogenital, Body: Pelvis, Cross-organ: Cancer

Magnetic resonance imaging (MRI) is considered the modality of choice for the local staging of endometrial carcinoma. The findings at MRI in combination with histopathologic findings from endometrial sampling are used for pre-operative treatment planning. However, accurate risk assessment requires information typically obtained at the time of hysterectomy including the presence of lymphovascular space invasion (LVSI), tumour grade and if available the tumour molecular classification. Quantitative analysis and radiomics of pre-operative MRI scans has the potential to noninvasively improve risk stratification and optimize management paradigms in patients with endometrial carcinoma.
14:30   Placental Oxygenation: Implications of Quantification Patricia Grant
15:00   Fetal MRI: Is There a Role for Quantitation? Catherine Limperopoulos
 

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.